Women who delivered at Juntendo University Hospital between April 2015 and October 2021 who were declared obstetric massive hemorrhage and treated with fibrinogen replacement therapy
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Women who gave birth at Juntendo Hospital between April 2015 and October 2021 who were declared obstetric massive hemorrhage and treated with fibrinogen replacement therapy
Exclusion criteria
Exclusion criteria: Patients with congenital hypofibrinogenemia, pregnancy <22 weeks, measurement errors, missing data, and patients transported from other hospitals who had received antithrombin or recombinant active clotting factor VII were excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Elevated fibrinogen levels by FRT in DIC and non-DIC groups | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood coagulation data including fibrinogen levels before and after FRT, Blood loss and transfusion volume before and after FRT, Time from onset of bleeding to hemostasis, Time from start of treatment to hemostasis | — |
Countries
Japan
Contacts
Juntendo University Urayasu Hospital Department of Anesthesiology and Pain Medicine